Dr. Menegatti has been awarded a research grant by the National Science Foundation to work on a stem cell distillery that can gently separate desired from undesired cells based on therapeutic potential. Beyond the potential benefits to American healthcare that this research could reap, this grant will help grow our lab by allowing him to expand the breadth of his projects and, in the process, support more students, postdocs, and undergraduate researchers.
These grants are highly competitive, awarded only to a small percentage of applicants, and are provided with the goal of having a broad impact on both the researcher and on the progress of human technology. Our lab’s focus on the cutting edge of drug delivery, chemistry, and bioseparations promise to bring new innovations to the table and advance scientific and engineering practices for the coming century.
To learn more about the NSF, please visit their website. To learn more about our upcoming projcet, feel free to read the award page for grant number 1743404.
In the Biopep group, as well as in the Chemical Engineering department and NC State as a whole, we strive to make one of our most valuable products be the whole person that graduates from their experience here. An important part of graduate education is leadership through teaching and guiding undergraduate students, and here at the Biopep group we’re no strangers to striving for excellence in every field.




The European Patent Office has approved the patent, number EP3004136, filed by Dr. Menegatti for the purification of IgG using peptoid affinity ligands. We think this is the beginning of an incredible journey with a new set of chemistries, one that will have many of the positive traits of our lab’s traditional expertise with peptides but the added bonuses of chemical stability. More peptoid work from us is on the horizon as we continue to work on the cutting edge of biotechnology and bioprocessing.